Citigroup »

Sarepta Therapeutics note 1.500% 11/1 shares owned by Citigroup

Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Sarepta Therapeutics note 1.500% 11/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics note 1.500% 11/1 held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4k 1.0k 1.41
2023-09-30 $493k 279k 1.77
2023-03-31 $294k 152k 1.93
2022-12-31 $999k 535k 1.87
2022-09-30 $837k 502k 1.67
2021-03-31 $40k 31k 1.29
2020-12-31 $25k 10k 2.50
2019-06-30 $533k 239k 2.23
2019-03-31 $5.6M 3.1M 1.80

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Ishares Tr Msci Emg Mkt Etf (EEM)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Sarepta Therapeutics note 1.500% 11/1

DLD Asset Management
Point72 Asset Management
D. E. Shaw & Co
CSS
Capstone Investment Advisors
Worth Venture Partners
Bank of America Corporation
Palisade Capital Management
Warberg Asset Management
Wolverine Asset Management
Bnp Paribas Arbitrage, Snc
Fox Hill Wealth Management
Virtus Investment Advisers
Royal Bank of Canada
Citigroup

View all funds holding Sarepta Therapeutics note 1.500% 11/1